Mylan N.V. (MYL) Upgraded to “Sell” at BidaskClub

BidaskClub upgraded shares of Mylan N.V. (NASDAQ:MYL) from a strong sell rating to a sell rating in a research report report published on Thursday.

A number of other equities research analysts also recently weighed in on the stock. ValuEngine downgraded shares of Mylan N.V. from a buy rating to a hold rating in a research note on Friday, September 1st. Argus downgraded shares of Mylan N.V. from a buy rating to a hold rating and reduced their price target for the company from $47.59 to $29.39 in a research note on Tuesday, August 22nd. Mizuho restated a buy rating and issued a $37.00 price target (down from $53.00) on shares of Mylan N.V. in a research note on Sunday, August 20th. Citigroup Inc. upgraded shares of Mylan N.V. from a neutral rating to a buy rating and raised their price target for the company from $36.00 to $42.00 in a research note on Wednesday, August 16th. Finally, UBS AG restated a buy rating and issued a $46.00 price target (down from $50.00) on shares of Mylan N.V. in a research note on Thursday, August 10th. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company’s stock. The company currently has an average rating of Hold and an average target price of $43.43.

Mylan N.V. (MYL) opened at 32.10 on Thursday. The firm has a market capitalization of $17.21 billion, a price-to-earnings ratio of 25.95 and a beta of 1.31. Mylan N.V. has a 12 month low of $29.39 and a 12 month high of $45.87. The stock’s 50 day moving average is $33.17 and its 200-day moving average is $37.91.

Mylan N.V. (NASDAQ:MYL) last posted its quarterly earnings results on Wednesday, August 9th. The company reported $1.10 earnings per share for the quarter, missing analysts’ consensus estimates of $1.18 by $0.08. Mylan N.V. had a net margin of 5.51% and a return on equity of 22.42%. The company had revenue of $2.96 billion during the quarter, compared to analyst estimates of $3 billion. During the same quarter in the previous year, the business posted $1.16 earnings per share. The company’s revenue for the quarter was up 15.7% on a year-over-year basis. Equities analysts anticipate that Mylan N.V. will post $4.52 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be read at https://sportsperspectives.com/2017/09/11/mylan-n-v-myl-upgraded-to-sell-at-bidaskclub.html.

Hedge funds and other institutional investors have recently modified their holdings of the company. Advisors Capital Management LLC lifted its position in shares of Mylan N.V. by 4.7% in the 2nd quarter. Advisors Capital Management LLC now owns 86,329 shares of the company’s stock worth $3,351,000 after purchasing an additional 3,854 shares during the period. Wade G W & Inc. lifted its position in shares of Mylan N.V. by 3.6% in the 1st quarter. Wade G W & Inc. now owns 6,156 shares of the company’s stock worth $240,000 after purchasing an additional 213 shares during the period. Mn Services Vermogensbeheer B.V. lifted its position in shares of Mylan N.V. by 508.8% in the 2nd quarter. Mn Services Vermogensbeheer B.V. now owns 73,842 shares of the company’s stock worth $2,867,000 after purchasing an additional 61,712 shares during the period. Baird Financial Group Inc. lifted its position in shares of Mylan N.V. by 10.0% in the 1st quarter. Baird Financial Group Inc. now owns 756,355 shares of the company’s stock worth $29,490,000 after purchasing an additional 68,967 shares during the period. Finally, Canada Pension Plan Investment Board lifted its position in shares of Mylan N.V. by 32.8% in the 2nd quarter. Canada Pension Plan Investment Board now owns 610,319 shares of the company’s stock worth $23,693,000 after purchasing an additional 150,906 shares during the period. Hedge funds and other institutional investors own 71.97% of the company’s stock.

About Mylan N.V.

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Analyst Recommendations for Mylan N.V. (NASDAQ:MYL)

Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply